A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses)

Clinical trial NCT04979572 · COMPLETED

Trial details

NCT number: NCT04979572
Sponsor: Taisho Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Subjects

Start date: 2021-08-16
Primary completion: 2022-01-26
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.